News - Page 251 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Dr. Roger McIntyre Elected Board Chair of Champignon Brands Inc.

Dr. Roger McIntyre Elected Board Chair of Champignon Brands Inc.

Post published:October 5, 2020
Post category:Press Release

Read more about the article MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines

MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines

Post published:October 5, 2020
Post category:Press Release

Read more about the article Celia Morgan, Professor of Psychopharmacology at University of Exeter and Leading Ketamine Investigator, Joins AWAKN Life Sciences

Celia Morgan, Professor of Psychopharmacology at University of Exeter and Leading Ketamine Investigator, Joins AWAKN Life Sciences

Post published:October 2, 2020
Post category:Press Release

Read more about the article Field Trip to List on CSE on or around 7th October under ticker FTRP

Field Trip to List on CSE on or around 7th October under ticker FTRP

Post published:October 2, 2020
Post category:Press Release

Read more about the article Thoughtful Brands Closes $600,000 Private Placement

Thoughtful Brands Closes $600,000 Private Placement

Post published:September 30, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today

Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today

Post published:September 30, 2020
Post category:Press Release

Read more about the article Red Light Holland’s Science and Innovation Division, Scarlette Lillie, Announces Collaboration with Jinfiniti Precision Medicine to Pursue Clinical Study Insights

Red Light Holland’s Science and Innovation Division, Scarlette Lillie, Announces Collaboration with Jinfiniti Precision Medicine to Pursue Clinical Study Insights

Post published:September 30, 2020
Post category:Press Release

Read more about the article Mind Cure Announces Kelsey Ramsden as new Chief Operating Officer

Mind Cure Announces Kelsey Ramsden as new Chief Operating Officer

Post published:September 29, 2020
Post category:Press Release

Read more about the article Field Trip Psychedelics Inc. Announces Successful GLP Synthesis, Results From Initial Preclinical Testing for FT-104, its First Molecule in Development

Field Trip Psychedelics Inc. Announces Successful GLP Synthesis, Results From Initial Preclinical Testing for FT-104, its First Molecule in Development

Post published:September 29, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Announces Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Announces Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

Post published:September 29, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.